Pembrolizumab in patients with advanced non-small-cell lung cancer (KEYNOTE-001): 3-year results from an open-label, phase 1 study
- Resource Type
- Article
- Authors
- Leighl, Natasha B ; Hellmann, Matthew D; Hui, Rina; Carcereny, Enric; Felip, Enriqueta; Ahn, Myung-Ju; Eder, Joseph Paul; Balmanoukian, Ani S; Aggarwal, Charu; Horn, Leora; Patnaik, Amita; Gubens, Matthew; Ramalingam, Suresh S; Lubiniecki, Gregory M; Zhang, Jin; Piperdi, Bilal; Garon, Edward B
- Source
- In The Lancet Respiratory Medicine April 2019 7(4):347-357
- Subject
- Primary Research
Articles
- Language
- ISSN
- 2213-2600